Skip to content
PeptideGeek

Weight loss

5-Amino-1MQ, explained simply

A small molecule that blocks a fat-cell enzyme called NNMT — studied in animals for fat loss and healthier metabolism. No human trials yet.

Animal and lab studies onlyInjection under the skin (like insulin shots)5 cited sourcesResearch compound — not FDA approved

Start here

What is 5-Amino-1MQ?

5-Amino-1MQ is a small lab-made molecule — not technically a peptide — built to block an enzyme in fat cells called NNMT, a cellular machine that slows how cells burn energy 1. In obese mice it reduced body weight and fat 1 and improved blood sugar 2, but it has never been tested in humans. It is a research compound with no FDA approval, no proven human dose, and no human safety record.

How it works in your body

Imagine your fat cells have a drain that slowly lets out the fuel they need to burn energy. That drain is an enzyme called NNMT. 5-Amino-1MQ plugs the drain. With the drain plugged, the cell keeps more fuel (NAD+) and burns fat instead of storing it 1. In mice, this led to less body fat and smaller fat cells 1.

Why researchers care

This is early-stage science. Every result so far comes from mice and lab dishes — there are no human trials yet 12. In obese mice, doctors found real, repeatable fat loss and better blood sugar without the animals eating less 12. That is exciting, but it does not prove the same thing happens in people. Anyone considering 5-Amino-1MQ should know it is an experimental compound with no proven human dose and no human safety record.

The deeper mechanism, for the curious

An enzyme called NNMT (nicotinamide N-methyltransferase) takes a methyl group (a small chemical tag) from SAM (S-adenosylmethionine, the cell's main supply of these tags) and attaches it to nicotinamide (a form of vitamin B3). This makes 1-MNA (1-methylnicotinamide) and SAH (S-adenosylhomocysteine). This one reaction drains two supplies at once. It uses up nicotinamide, which your cells would otherwise recycle into NAD+ (a molecule cells need to make energy) through the salvage pathway (the cell's recycling route). It also burns through SAM 4. When NNMT runs fast in fat tissue, NAD+ and SAM stay low and energy expenditure drops. 5-Amino-1MQ looks like nicotinamide. It sticks to the active site of NNMT (the spot where the enzyme does its work) and competes with the real target, so the enzyme cannot process it 4. In fat cells grown in a lab, this lowered 1-MNA and raised both NAD+ and SAM, which suppressed the building of new fat 1. Importantly, the compound is highly selective. It does not block related SAM-using enzymes or the enzymes that recycle NAD+, and it crosses cell membranes well, which is unusual for this class of compound 1. One caveat from later work: at higher lab concentrations the compound also blocked monoamine oxidase-A (an enzyme that breaks down mood-related brain chemicals). This is an off-target effect (an effect on something other than the intended target) worth watching 2.

Evidence check

Animal and lab studies only

No human trials exist. Everything known about it comes from animals or cells in a dish — treat every claim with caution.

Every numbered marker on this page links to one of the 5 sources at the bottom.

75/100

Fat and weight reduction

The strongest animal finding, with its numbers: in 9 diet-induced obese mice treated for 11 days, epididymal white adipose mass fell about 35% (p<0.001) and adipocyte size by more than 30% (p<0.05) against 9 controls, while body weight fell 5.1% in treated mice as controls gained 1.4%. Food intake did not differ between the groups, so the effect was metabolic rather than appetite-driven. Mice, 11 days, nine animals — strong for what it is, and unproven in humans.

65/100

Blood measures of metabolism

Total cholesterol in the blood was about 30% lower in treated mice than controls (p<0.05), bringing it in line with the vendor's figures for age-matched normal-chow mice. A second mouse study reported improvements in insulin, glucose tolerance, triglycerides (blood fats) and liver fat. No human measurement of any of these exists for this compound.

60/100

NAD+ (a cell energy molecule) / cellular energy

The mechanism is well characterised in cells: blocking NNMT cuts production of 1-MNA and raises intracellular NAD+ and SAM, with an EC50 of 2.3 ± 1.1 µM in cultured adipocytes. It is selective — no inhibition of DNMT1, PRMT3, NAMPT or SIRT1 at tested concentrations. That the mechanism works in a dish is not the same as a benefit in a person.

What the research points to

The most-asked question

How much 5-Amino-1MQ do I take?

The research-reported range is No human dose has been established.

  1. Community practice — listed because it is used, not because it is evidenced

    50 – 150 mg/day (community-reported, no trial)

    • How often
      Once daily, per community protocols
    • For how long
      Undefined — no human study has run any duration

    This is not a dose anyone established; it is the range people report using. The absence of human data here was checked rather than assumed: PubMed has no record under "5-amino-1MQ" and no clinical study of any NNMT inhibitor in people, ClinicalTrials.gov has no registered study of either the compound or the target, and no company has announced a clinical programme. The EU and WHO trial registries were not searched directly, so a trial registered only outside the US cannot be ruled out. With no human trial, there is no human safety data and no established human maximum, so there is nothing to describe any of these figures as tolerated against. It is shown as a single range rather than as starting, standard and advanced steps because no study set those steps — whether people using it escalate through them is a question about community practice that has not been checked here. The numbers that do exist are animal data only and do not convert to a human dose: mice received about 34 mg/kg a day by subcutaneous (under the skin) injection, 20 mg/kg three times daily for 11 days, n=9 1. In a dose-escalation study spanning 10 to 150 mg/kg/day, 60 mg/kg/day produced no observable adverse effects — in TWO mice 1. Lab screening found off-target monoamine oxidase-A inhibition at higher concentrations, so caution with MAO-sensitive drugs and foods is reasonable 2, and the compound is cytotoxic to cultured pre-adipocytes at high concentration — about 40% loss of viability at 600 µM against none at 10 µM 1.

Adjusting your dose

You're at the right dose if…

Consider going up if…

  • A lower dose is well tolerated with no side effects after several weeks (community practice, not clinically validated)

Go down if…

The ceiling: No established human maximum — human dosing has never been studied 1

Reconstitution, in plain words

How do I mix 5-Amino-1MQ?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for 5-Amino-1MQ:

What you need

  • 5-Amino-1MQ (oral capsules do not need mixing)
  • For injectable powder: bacteriostatic water
  • Insulin syringe
  • Alcohol swabs
  • Sterile vial

A worked example

5-Amino-1MQ is most often supplied as oral capsules, which need no reconstitution. If you have a lyophilized (freeze-dried) powder for injection, a typical approach is to add 2 mL of bacteriostatic water to a vial containing 50 mg, giving 25 mg per mL. Note: injectable dosing for this compound has no human study behind it.

Working out your dose

With 25 mg/mL solution, a 50 mg dose would be 2 mL. Because no human dose is established, any injectable use is experimental. Capsule users simply take the labeled capsule strength.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with 5-Amino-1MQ's recorded schedule.

5-Amino-1MQOnce daily, per community protocols

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Injection sites & technique

Where do I inject 5-Amino-1MQ?

The best spots

  • Abdomen (subcutaneous (under the skin), if injected)
  • Upper thigh (subcutaneous, if injected)

How to do it, step by step

  • Most community users take capsules by mouth with water
  • If injecting, pinch the skin and insert at a 45-90 degree angle into the fat layer
  • Rotate sites to avoid irritation
  • No injection technique has been validated for humans with this compound

Capsule by mouth is the most common route among community users; injection under the skin was used in animal studies 12

Timing

When do I take 5-Amino-1MQ?

Best time of day

Community users typically take it in the morning; no human study has tested timing.

With or without food?

Can be taken with or without food (community practice); no peer-reviewed guidance exists.

Taking it with other peptides

Some community users stack it with NAD+ precursors like NMN or NR because 5-Amino-1MQ raises NAD+ by a different route 1. This combination has never been tested together in humans.

The honest list

What side effects could 5-Amino-1MQ cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

Less common

Worth knowing about, but most people never see these.

  • Fatigue or flushing (community-reported)

    Occasional community reports mention tiredness or warmth/flushing. These are not peer-reviewed findings.

    What to do Reduce the dose or discontinue and reassess with a healthcare provider.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

  • Possible effects on MAO-A (an enzyme that breaks down mood-related brain chemicals), beyond the intended target (theoretical)

    Lab screening showed the compound can block monoamine oxidase-A at higher concentrations 2. MAO-A affects how the body handles certain brain chemicals and foods, so combining with MAO-sensitive drugs or tyramine-rich foods is a theoretical concern.

    What to do Avoid combining with MAO inhibitors, SSRIs, or tyramine-rich foods without medical guidance. Seek care for severe headache, racing heart, or high blood pressure.

  • Unknown long-term and human risks

    No long-term or human safety data exists. Rare or delayed harms cannot be ruled out.

    What to do Use only with informed caution and ideally medical supervision. Stop and seek care for any severe or unexpected symptom.

Week by week

What should I expect from 5-Amino-1MQ, and when?

  1. Weeks 1-2

    You might notice
    What's normal
    • Feeling no different early on is expected
    • This is not a fast-acting stimulant
    What's next
    • Focus on tolerating the compound and watching for any side effects

  2. Weeks 3-6

    You might notice
    What's normal
    • Slow, steady change (if any) rather than dramatic shifts
    • Any effect in humans is unproven
    What's next
    • Reassess how you feel and whether to continue
    • Keep diet and activity consistent so you can judge honestly

  3. Weeks 7-12

    You might notice
    What's normal
    • A full cycle in community protocols runs roughly 8-12 weeks
    What's next
    • Take a break and reassess
    • There is no evidence on safe long-term continuous use in humans

How to tell it's actually working

Physical Response Indicators

Subjective Changes

  • Community users report a sense of steadier energy (anecdotal, not verified)
  • No validated subjective markers exist for this compound in humans

Measurable Signs in Tests (if tested)

Not seeing anything? The usual reasons

Is it right for you?

Who should avoid 5-Amino-1MQ?

Do not use it if…

  • You are pregnant or breastfeeding
  • You take an MAO inhibitor
  • You want only treatments proven safe and effective in humans

Be extra careful if…

When to stop

This is an experimental research compound with no human safety data. This information is educational and not medical advice. Talk to a qualified healthcare provider before using it and before stopping any prescribed medication.

What it mixes badly (and well) with

Medications

Other peptides

Supplements

Who it tends to suit

Fat loss research

The clearest, most repeated finding: obese mice lost body weight and fat mass on 5-Amino-1MQ without eating less 12. This is the main reason people are interested — though it is animal data, not human proof.

Metabolic health support

In mice, it improved blood sugar, insulin, and liver fat 2. Researchers see NNMT inhibition as a promising angle for metabolic syndrome 4.

NAD+ (a cell energy molecule) and how cells make energy

By blocking NNMT, it raises NAD+ and SAM inside cells, which supports how cells make and use energy 14. This makes it interesting to people studying aging and metabolism.

The safety picture overall

The honest picture: nobody has run a human safety trial on 5-Amino-1MQ, so everything below is from mice and cultured cells. In the 11-day mouse study, 9 treated animals lost 2.0 ± 0.6 g of body weight (about 5.1% from baseline) while 9 controls gained 0.6 ± 0.4 g, with no difference in food intake and no observable adverse effects reported 1. The tolerability ceiling people quote comes from a dose-escalation study spanning 10 to 150 mg/kg/day in TWO mice, where 60 mg/kg/day produced no observable adverse effects 1 — a denominator worth seeing before treating it as a safety margin. In cultured pre-adipocytes the compound is cytotoxic at high concentration: no effect on viability at 10 µM, modest cytotoxicity from 100 to 300 µM, and roughly 40% loss of viability at 600 µM 1. Lab screening also found off-target inhibition of monoamine oxidase-A at higher concentrations 2. Short studies in mice cannot rule out problems that appear over months or years in people. Treat this as an experimental compound and talk to a doctor first, particularly if you take any medication.

All safety information comes from animal studies. The absence of human data here was checked rather than assumed: PubMed has no record under "5-amino-1MQ" and no clinical study in people of any drug blocking its target (an enzyme called NNMT), ClinicalTrials.gov has no registered study of either the compound or the target, and no company has announced a human trial programme. The EU and WHO trial registries were not searched directly, so a trial registered only outside the US cannot be ruled out. The main mouse study gave 20 mg/kg per injection under the skin three times daily — about 34 mg/kg/day — to 9 obese mice (made obese by diet) for 11 days, against 9 saline controls 1; a second used 10-32 mg/kg once daily for about a month 2. Those are animal doses and do not convert to human milligram doses. One discrepancy worth knowing if you read around: secondhand write-ups describe the mouse study as dosing through drinking water at about 40 mg/kg/day. The primary paper, read in full, describes injection under the skin at 20 mg/kg three times daily 1. On precision: the compound did not block several related enzymes (DNMT1, PRMT3, NAMPT or SIRT1) at tested concentrations, and blocked COMT only 10% at 600 µM 1 — in other words, it hits its intended target cleanly at relevant concentrations, with an effect on MAO-A (an enzyme that breaks down mood chemicals) appearing only at higher ones 2. How it moves through the human body, its long-term safety, and an effective human dose are all unknown. Note also that this is a small molecule, not a peptide — it is catalogued here because people ask about it alongside peptides.

Keeping it good

How do I store 5-Amino-1MQ?

Before mixing (powder)

Store capsules or sealed powder in a cool, dry place away from light. Refrigeration is recommended for powder to preserve stability.

After mixing (liquid)

If reconstituted for injection, keep refrigerated at 2-8 degrees C and use within a few weeks. Do not freeze the solution.

Signs it has gone bad

  • Cloudiness or particles in a solution that should be clear
  • Color change from the normal brown/reddish tint
  • Any off smell
  • Capsules that look damp or clumped

Not our opinion — the published record

What the studies actually found about 5-Amino-1MQ

2018

Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice

The foundational study. In mice made obese by diet, 5-amino-1MQ at 20 mg/kg given three times daily for 11 days clearly reduced body weight and white fat mass, shrank fat cells, and lowered cholesterol in the blood. Food intake did not change and no harmful effects were seen. The compound was highly selective for NNMT (the target enzyme) and could pass through cell membranes. Published in Biochemical Pharmacology, volume 147, pages 141-152.

Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ

2024

Nicotinamide N-methyltransferase Inhibition Mitigates Obesity-Related Metabolic Dysfunctions

In mice made obese by diet, 5-amino-1MQ at 10 or 32 mg/kg once daily by injection under the skin for 28-30 days held back weight gain in a dose-dependent way (bigger dose, bigger effect). It also lowered fasting insulin, improved the body's handling of a sugar drink, reduced triglycerides (blood fats), and cut liver fat (hepatic steatosis) by up to 73% at the high dose, while bringing liver enzymes back to normal. There were no serious side effects. A screen for off-target effects (effects on things other than the intended target) showed the compound blocked monoamine oxidase-A (an enzyme that breaks down mood-related brain chemicals) at 10 micromolar. Published in Diabetes, Obesity and Metabolism, volume 26, issue 11.

Babula JJ, Bui D, Stevenson HL, Watowich SJ, Neelakantan H

2022

Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice

In obese mice, combining a reduced-calorie diet with 5-amino-1MQ (32 mg/kg by injection under the skin) gave body weight and fat mass no different from lean control animals. This was better than diet change alone. It also shifted the gut microbiome (the community of gut bacteria), increasing Lactobacillus. Published in Scientific Reports.

Dimet-Wiley A, Wu Q, Wiley JT, Eswar A, Neelakantan H, Savidge T, Watowich SJ

2024

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome

A review explaining how the NNMT enzyme uses SAM (a molecule cells use as a chemical tag supply) to attach a methyl group (a small chemical tag) to nicotinamide (a form of vitamin B3) and make 1-methylnicotinamide. This uses up the building blocks for NAD+ (a molecule cells need to make energy) and raises homocysteine (an amino acid linked to heart risk). The review describes 5-amino-1MQ as a look-alike of nicotinamide that blocks NNMT by competing with it. It is highly selective, and it reversed obesity in mice on a high-fat diet by raising NAD+ and lowering fat mass. Published in Frontiers in Pharmacology, volume 15, article 1410479.

Sun WD, Zhu XJ, Li JJ, et al.

2024

PubChem Compound Summary: 5-Amino-1-methylquinolinium (CID 950107)

An official chemical database record that confirms what 5-amino-1-methylquinolinium is and how it is built: molecular formula C10H11N2+ (the charged form), molecular weight 159.21 g/mol, PubChem CID 950107, salt CAS 42464-96-0.

National Center for Biotechnology Information (NCBI)

If this isn't the right fit

What people use instead of 5-Amino-1MQ

Proven weight loss in humans

  • GLP-1 medications like semaglutide or tirzepatide (FDA-approved and studied in humans)
  • Mazdutide (advanced human trials)

Raising NAD+ levels (NAD+ is a molecule cells use to make energy)

  • NMN (nicotinamide mononucleotide)
  • NR (nicotinamide riboside)

Your questions

5-Amino-1MQ FAQ

Is 5-Amino-1MQ actually a peptide?

No. Despite being sold alongside peptides, 5-Amino-1MQ is a small chemical molecule (a methylquinolinium compound), not a peptide made of amino acids. It works by blocking an enzyme called NNMT 4.

Has 5-Amino-1MQ been tested in humans?

No. Every published study is in mice or lab dishes 123. There are no human clinical trials, so its effects and safety in people are unknown.

How does it help with fat loss?

In fat cells, an enzyme called NNMT wastes molecules (NAD+ and SAM) your cells use to burn energy. 5-Amino-1MQ blocks NNMT, so cells keep more of that fuel and lean toward burning fat instead of storing it. In obese mice this led to less body fat without the animals eating less 1.

What dose do people use?

There is no proven human dose. Community protocols commonly cite 50-150 mg per day by mouth, but that is not backed by any human study. Animal studies used 10-32 mg/kg by injection, which does not convert directly to a human pill dose 12.

Are there any safety concerns?

The biggest concern is simply that human safety is unknown. Lab screening also found it can block monoamine oxidase-A (MAO-A) at higher concentrations, so it should not be combined with MAO inhibitors and should be used cautiously with serotonergic drugs or tyramine-rich foods 2. Talk to a doctor first.

5 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the 5-Amino-1MQ research profile on Peptide Initiative.

  1. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in miceNeelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ · 2018
  2. Nicotinamide N-methyltransferase Inhibition Mitigates Obesity-Related Metabolic DysfunctionsBabula JJ, Bui D, Stevenson HL, Watowich SJ, Neelakantan H · 2024
  3. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO miceDimet-Wiley A, Wu Q, Wiley JT, Eswar A, Neelakantan H, Savidge T, Watowich SJ · 2022
  4. Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndromeSun WD, Zhu XJ, Li JJ, et al. · 2024
  5. PubChem Compound Summary: 5-Amino-1-methylquinolinium (CID 950107)National Center for Biotechnology Information (NCBI) · 2024

Want the deep science?

Read the full 5-Amino-1MQ research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More weight loss guides

This guide is education, not medical advice. 5-Amino-1MQ is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.